Partners in Health together with the TB Coalition of the Americas are pleased to invite you to apply to participate in the 1st Regional Workshop for Socialization and Awareness in the ENGAGE-TB approa...

dear all, I am happy to inform that Infection control trends July 2019 edition is dedicated to Tuberculosis. since India is strongly committed to eliminate tuberculosis and WHO theme is on end TB s...

Dear Colleagues, Applications are now open for the positions of Project Officer and Team Leader to join the RID-TB team in Daru. For full details including how to apply, please go to the links ...

In The Hague this week, the WHO, the Public-Private Mix Working Group of the Stop TB Partnership, and global partners have just released a Roadmap to scale up the engagement of public and private heal...

Hello colleagues, I was recently asked about "certification" for a new TB unit/ward in Canada. We do have ventilation standards through our Canadian Standards Association (CSA). I know that this ...

Please see this new paper in PLoS Medicine, based on our large, two-city study on quality of TB care delivered by private sector providers in India. The study used standardized (simulated) patients to...

Dear GHD Online, Six new technical publications from the Challenge TB Project are now available on the MSH website. They showcase regional efforts and country-specific work in Afghanistan, Banglade...

Dear all, it is my pleasure and a moment of proud and honor to bring out a new e-newsletter of national level for circulation in India and other resource poor countries along with our editorial team...

Hi All: This is Mohammed Saiful Islam, a PhD student from University of New South Wales, Sydney, Australia. For my PhD dissertation, I have been working on Tuberculosis policies and their implement...

dear experts, what are the multicopy amplification targets in expert ultra? how do they improve the sensitivity of the assay? do they reduce the specificity of the assay? Multicopy apmlification...

Hi All, Please see this new paper. Key finding is the emergence of BRICS as major TB research producers and funders. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0199706 Bes...

Dear colleagues! Does anyone of you have an experience of simultaneous treatment of a patient with anti-tuberculous and direct acting antiviral drugs for HCV-infection? What are the official approac...

Dear colleagues, The WHO European Region has faced high rates of external and internal migration in recent years, with concerns that this is contributing to the burden of tuberculosis (TB), multid...

Dear all, This is to inform you all that nationwide survey to know basic infection control practices has been flagged off by myself in association with Clean india journal. This is baseline surve...

Here is a recent update on the search for improved treatments. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies Simon Tiberi, Nelit...

Dear colleagues -- I attempted an educational piece for a lay audience about the urgency of TB in school settings and brought in infection control issues. Here is the link to it. I would appreciate ...

Is M.fortuitum naturally pyrazinamide resistant all the time? PZA resistance in M.fortuitum Ranjan Perera

Hi there! My name’s Andrew. I’m a designer/researcher at 18F/GSA working with NIH/NCBI’s PubMed team to better understand the experiences of people who search for biomedical literature (to potentially...

Hello members! I'm part of a research team working to respond to this call for papers http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32903-3/fulltext. The group includes women ...

Dear colleagues, Please find a recent publication of WHO Regional Office for Europe, with thanks to inputs of many of you. "Tuberculosis (TB), and especially drug-resistant TB, is a public heal...